Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Cellectis S.A. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −2 vs. Q4 2024
- Shares held
- 13.6M
- +843.0K (+6.6%) vs. Q4 2024
- Total value
- $16.9M
- −$6.10M (−26.6%) vs. Q4 2024
- New holders
- 3
- 6 more added
- Sold out
- 5
- 8 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Asset Management Americas Inc | 4,722,664 | $5.86M | 0.00% | +3,284,409+228.4% | Added |
| Long Focus Capital Management, LLC | 4,717,293 | $5.85M | 0.40% | +100,000+2.2% | Added |
| B Group, Inc. | 3,256,501 | $4.04M | 3.51% | +175,000+5.7% | Added |
| Macquarie Group Ltd | 226,875 | $281.0K | 0.00% | 00.0% | Unchanged |
| Baillie Gifford & Co | 139,047 | $172.4K | 0.00% | −151,382−52.1% | Reduced |
| Millennium Management LLC | 103,854 | $128.8K | 0.00% | −430,697−80.6% | Reduced |
| Morgan Stanley | 86,795 | $107.6K | 0.00% | −111,899−56.3% | Reduced |
| LPL Financial LLC | 84,747 | $105.1K | 0.00% | −525−0.6% | Reduced |
| UBS Group AG | 44,475 | $55.1K | 0.00% | −184,606−80.6% | Reduced |
| Acadian Asset Management LLC | 46,377 | $55.0K | 0.00% | +26,461+132.9% | Added |
| BNP Paribas Arbitrage, SA | 38,100 | $47.2K | 0.00% | +15,700+70.1% | Added |
| First Affirmative Financial Network | 25,860 | $32.1K | 0.02% | −30.0% | Reduced |
| Old Mission Capital LLC | 25,289 | $31.4K | 0.00% | +25,289 | New |
| Wells Fargo & Company | 22,750 | $28.2K | 0.00% | −1,840−7.5% | Reduced |
| Baird Financial Group, Inc. | 15,090 | $18.7K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 10,859 | $13.5K | 0.00% | +10,859 | New |
| Geode Capital Management, LLC | 10,776 | $13.4K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 10,711 | $13.3K | 0.00% | +10,711 | New |
| Harbour Investments, Inc. | 4,500 | $5.58K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 3,600 | $4.43K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 2,115 | $2.62K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1,600 | $2.42K | 0.00% | +1,100+220.0% | Added |
| JPMorgan Chase & Co | 1,697 | $2.10K | 0.00% | −3,876−69.5% | Reduced |
| POM Investment Strategies, LLC | 495 | $614 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 77 | $95 | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 52 | $94 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 13 | $16 | 0.00% | 00.0% | Unchanged |
| Capital International Investors | 0 | $0 | 0.00% | −1,848,804−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −34,786−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −27,322−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,526−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −303−100.0% | Sold out |